Mode
Text Size
Log in / Sign up

Pulmonary TB History Linked to Higher COPD OddsPast tuberculosis infection significantly increases risk of developing lung disease

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Prior pulmonary TB is a strong risk factor for COPD, with 2.65 times higher odds.

A comprehensive meta-analysis examined the link between a history of pulmonary tuberculosis (TB) and chronic obstructive pulmonary disease (COPD). Pooling data from multiple studies involving over 1 million participants, the analysis found that individuals with prior pulmonary TB had significantly higher odds of developing COPD.

The overall odds ratio was 2.65 (95% CI: 2.14–3.28), indicating a strong association. Subgroup analyses by study design showed consistent results: case-control studies had an odds ratio of 4.92, cross-sectional studies 2.64, and cohort studies 2.46. Regional analyses also revealed positive associations across Asia, Africa, the Americas, and Europe, with the strongest effect in Africa (odds ratio 9.36).

Among pulmonary TB survivors, the prevalence of COPD was 34%, while among COPD patients, 17% had a history of pulmonary TB. These findings underscore the substantial burden of COPD in TB survivors.

The study had notable limitations, including high heterogeneity (I² = 94.9%) and potential small-study effects. However, sensitivity analyses indicated that the pooled estimates were reliable.

For clinicians, this meta-analysis highlights the importance of recognizing prior pulmonary TB as a significant risk factor for COPD. Patients with a history of TB should be monitored for respiratory symptoms and may benefit from early screening and preventive measures.

How this fits prior evidence

This meta-analysis addresses a gap in understanding long-term respiratory outcomes following infectious disease. While previous evidence confirmed that COPD patients have higher odds of diabetes mellitus (OR 1.39), this finding establishes pulmonary tuberculosis as a specific risk factor for the development of COPD, providing a clearer epidemiological link between prior infection and chronic obstructive lung disease.

Living with a history of tuberculosis (TB) can have long-lasting effects on your lungs. New research looking at over one million people shows that those who survived pulmonary TB are significantly more likely to develop chronic obstructive pulmonary disease (COPD). COPD is a condition that makes it hard to breathe and is often caused by long-term lung damage.

The study found that the risk of developing COPD was much higher for people with a history of TB compared to those without one. This link remained consistent across different types of studies and various parts of the world, including Asia, Africa, Europe, and the Americas. Specifically, about 34% of survivors of pulmonary TB were found to have COPD.

While the data shows a strong connection between these two conditions, it is important to remember that this is an observational study. This means researchers found a link, but they cannot prove that one caused the other directly. There was also some variation in how different studies were conducted, but the overall finding remains consistent: a history of TB is a significant risk factor for lung health.

What this means for you:
People who have had pulmonary tuberculosis face a much higher risk of developing chronic obstructive pulmonary disease.

Common questions

How much does a history of TB affect lung health?

People with a history of pulmonary tuberculosis have significantly higher odds of developing COPD. The study found that about 34% of people who survived pulmonary TB also had COPD.

Is this risk the same everywhere in the world?

Yes, the link between past tuberculosis and lung disease was found across different regions. Positive associations were reported in Asia, Africa, Europe, and the Americas.

How common is it for COPD patients to have had TB?

Among people who already have chronic obstructive pulmonary disease (COPD), about 17% were found to have a prior history of pulmonary tuberculosis.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedAug 2026
View Original Abstract ↓
BackgroundSurvivors of pulmonary tuberculosis (TB) frequently report chronic respiratory symptoms; however, the magnitude of the association with chronic obstructive pulmonary disease (COPD) and the reciprocal burden of COPD and TB in each population remain unclear. Hence, this review was conducted to determine the association between a history of pulmonary tuberculosis and chronic obstructive pulmonary disease.MethodsFollowing PRISMA 2020, we searched MEDLINE, Embase, Web of Science, and Scopus from inception to August 2025 for analytical observational studies comparing individuals with and without a history of pulmonary TB. Odds ratios (ORs) were pooled using random-effects inverse-variance models (DerSimonian–Laird). Heterogeneity (I2 and τ2) and small-study effects (using Egger’s test) were assessed. Prevalence meta-analyses were conducted to estimate the following: (i) COPD among pulmonary TB survivors and (ii) the prevalence of prior pulmonary TB among people with COPD.ResultsForty studies met the inclusion criteria. Twenty-six studies (n = 1,044,562) contributed to the association analysis: prior pulmonary TB was associated with higher odds of COPD (pooled OR = 2.65, 95% CI: 2.14–3.28), with substantial heterogeneity (I2 = 94.9%). When stratified by study design, pooled ORs were 4.92 for case–control studies, 2.64 for cross-sectional studies, and 2.46 for cohort studies. Across regions, positive associations were found in Asia (2.21), Africa (9.36), the Americas (3.60), and Europe (2.77). Egger’s test indicated small-study effects (p = 0.013), but sensitivity analyses showed that the pooled estimates were reliable. The pooled prevalence of COPD among survivors of pulmonary TB was 34% (95%CI: 28–40%). Among COPD patients, 17% (95% CI: 10–24%) reported a history of pulmonary TB.ConclusionA history of pulmonary TB was found to be a strong and consistent risk factor for COPD across different designs and regions, with a significant bidirectional burden. Integrating post-TB lung assessment (including spirometry), targeted COPD management, and risk-reduction strategies into TB programs is required.Systematic review registrationhttps://www.crd.york.ac.uk/PROSPERO/view/CRD420261415397, PROSPERO registration number is CRD420261415397.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.